Johnson & Johnson expects human trial of its Covid-19 vaccine by September

Global healthcare major Johnson & Johnson (J&J) on Monday said it expects to start human testing of its COVID-19 vaccine by September 2020 and anticipates that the first batch of vaccine could be available for emergency use authorisation in early 2021.

Through a partnership, the Biomedical Advanced Research and Development Authority (BARDA) and Johnson & Johnson together have committed more than $1 billion of investment to co-fund vaccine research, development, and clinical testing, Johnson & Johnson said in a statement.

J&J's lead vaccine candidate will enter